Lantheus Holdings (LNTH) Stock Falls as CMS Retains Current Reimbursement Method

Article's Main Image

Key Highlights for Investors:

  • Lantheus Holdings (LNTH, Financial) experiences an 8% stock decline due to CMS reimbursement decision.
  • Wall Street analysts provide a positive outlook with a potential 72.43% upside.
  • GuruFocus values suggest a 46.82% potential rise in stock price.

Lantheus Holdings (LNTH) experienced a noticeable 8% dip in its stock value after the Centers for Medicare & Medicaid Services (CMS) opted to maintain its current reimbursement method for diagnostic radiopharmaceuticals. This decision has shifted revenue expectations for Lantheus's key product, Plarify. Despite the decline, analysts present varied perspectives, with some indicating that the stock remains undervalued, offering potential stabilization opportunities in the future.

Wall Street Analysts Forecast

1945605516092928000.png

Wall Street analysts remain optimistic about Lantheus Holdings Inc (LNTH, Financial), as demonstrated by the one-year price targets provided by 13 analysts. The average target price is set at $128.31, with projections ranging from a low of $109.00 to a high of $159.00. This average target indicates a significant potential upside of 72.43% from the current price of $74.41, making it an attractive opportunity for investors. For more comprehensive estimate data, visit the Lantheus Holdings Inc (LNTH) Forecast page.

In terms of brokerage recommendations, Lantheus Holdings Inc (LNTH, Financial) currently boasts an average rating of 1.9 from 13 brokerage firms, signifying an "Outperform" status. On the rating scale of 1 to 5—where 1 is a Strong Buy and 5 is a Sell—this positions LNTH favorably in the eyes of analysts.

According to GuruFocus, the estimated GF Value for Lantheus Holdings Inc (LNTH, Financial) within a year is $109.25. This GF Value suggests a promising upside of 46.82% from the current price point of $74.41. The GF Value represents GuruFocus's assessment of the fair market value, derived from historical trading multiples, prior business growth, and future performance forecasts. For additional insights, explore the Lantheus Holdings Inc (LNTH) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.